We present the case of a 20-year-old male patient without previous history of cardiovascular disease who was admitted to our hospital with a new onset febrile sensation and chest pain. Chest computed tomography revealed a subpleural consolidation with a halo of ground-glass opacification. Blood tests revealed elevated levels of markers of myocyte necrosis (troponin I and creatine kinase-MB). Nasopharyngeal swab was positive for COVID-19. Cardiac MRI showed myocardial edema and late gadolinium enhancement compatible with myocarditis associated with COVID-19 infection. This case showed that acute myocarditis can be the initial presentation of patients with COVID-19 infection.
Background:
The objective of our study was to investigate the location, extension and type of novel coronavirus-induced disease 2019 (COVID-19) infection involvement and hepatic steatosis on initial chest computed tomography (CT). The relationship between fatty liver and severity of the disease was also investigated by measuring the liver attenuation index (LAI).
Methods:
This study evaluated the chest CT images of 343 patients (201 male, mean age 48.43 years) who were confirmed to have COVID-19, using nasopharyngeal swab. The chest CTs were analyzed for laterality, number of involved lobes, diffuseness, number of lesions, and lesion types. The CT attenuation values of liver and spleen were measured, and LAI was calculated for the detection of hepatic steatosis. Univariate and multivariate logistic regression analysis were used to identify the independent early predictors for severe COVID-19.
Results:
There was no significant difference between genders in terms of clinical course. Liver density and LAI were significantly lower in the intensive care unit (ICU) patients. The prevalence of severe disease was higher in the patients with hepatic steatosis than in the non-steatotic group (odds ratio [OR] 3.815, 95% confidence interval [CI] 1.97–7.37,
P
< 0.001). After adjusting for age and comorbidities including hypertension, diabetes mellitus, coronary artery disease, chronic obstructive pulmonary disease, and chronic kidney disease, multivariate logistic regression analysis showed that non-alcoholic fatty liver disease (NAFLD) was an independent risk factor for COVID-19 severity (OR 3.935, 95% CI 1.77-8.70,
P
= 0.001). The optimal cut-off value for LAI was calculated as 0.5 for predicting patients who required ICU treatment.
Conclusions:
On the initial chest CT images of COVID-19 patients, presence of fatty liver is a strong predictor for severe disease.
Aim: Chest computed tomography (CT) imaging plays a diagnostic and prognostic role in Coronavirus disease 2019 patients. This study aimed to investigate and compare predictive capacity of main pulmonary artery diameter (MPA), ascending aorta diameter (AAo), and MPA-to-AAo ratio to determine in-hospital mortality in COVID-19 patients.
Materials and methods:This retrospective study included 255 hospitalized severe or critical COVID-19 patients. MPA was measured at the level of pulmonary artery bifurcation perpendicular to the direction of the vessel through transverse axial images and AAo was measured by using the same CT slice at its maximal diameter. MPA-to-AAo ratio was calculated by division of MPA to AAo.
The association between serum angiogenin and osteopontin levels and coronary collateral circulation in patients with chronic total occlusion Objective: A well-developed coronary collateral circulation lowers both in-hospital and long-term morbidity and mortality limiting the infarct. Angiogenin (AGN) and osteopontin (OPN) are known to be potent inducers of angiogenesis. The aim of the present study was to investigate the relationship between serum ANG and OPN levels and collateral filling grade in subjects with stable coronary artery disease (SCAD). Methods: A total of 122 age-and gender-matched consecutive patients who were found to have total occlusion (n=70) and no significant stenosis in epicardial coronary arteries (n=52) who underwent coronary angiography due to SCAD between January 2015 and July 2017 were included in the study. AGN and OPN levels were measured using enzyme-linked immunosorbent assay. Coronary collateral circulation was graded using Rentrop's classification of collateral filling. Results: A total of 52 patients (61.60±11.78 years, 61.5% male) without significant epicardial coronary artery stenosis and 70 patients (62.87±8.24 years, 65.7% male) with totally occluded coronary arteries were included in the study. Subjects with total occlusion had significantly higher levels of AGN [122.
tracardiac mass was located in the left ventricle, anchoring in the posterior part of the interventricular septum. The mass measured 20x9x10 mm (longitudinal, transverse and craniocaudal diameters, respectively) attached by an 8.7 mm pedicle ( Fig. 1c and 1d). Cardiac surgery under cardiopulmonary by-pass was performed. Complete excision required a combined approach using aortotomy and transseptal left atriotomy. Initial transverse aortotomy revealed an inadequate access, given that it was difficult to achieve complete excision and safe the surgical resection margin because of the long distance from the aortic annulus to tumoral pedicle (4 cm) ( Fig. 1e). Left atrial transseptal approach revealed a pedunculated mass close to the mitral subvalvular apparatus, as seen in the intraoperative image (Fig. 1f). The tumor was completely resected. Diagnosis of left ventricular myxoma was confirmed during intraoperative examination and subsequently by histological analysis. Postoperative course was uneventful. Surgical treatment of left ventricular septal myxomas through combined atrial and aortic approach is infrequent. Distance mayor than 3 cm between aortic annulus or proximity and the mitral subvalvular apparatus may complicate surgical removal from an empty left ventricle.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.